Researchers Find Grape-Derived Compounds May Promote Resilience against Depression

News Scientists from the Icahn School of Medicine at Mount Sinai describe an extensive analysis of novel grape-derived compounds, dihydrocaffeic acid (DHCA) and malvidin-3'-O-glucoside (Mal-gluc),which might be developed as therapeutic agents for the treatment of depression. The study results indicate that... Contributed Author: Mount Sinai Hospital